Skip to main content

Table 2 LncRNAs and their roles in ATC

From: Molecular mechanisms of long non-coding RNAs in anaplastic thyroid cancer: a systematic review

LncRNA Tumor suppressor Oncogene CSC properties
AK139328 + N/D
BANCR + +
CASC2 + N/D
FOXD2-AS1 + +
GAS5 + N/D
H19 + N/D
HCP5 + N/D
HOTAIR + +
HOTAIRM1 + N/D
KLHL14-AS + N/D
Linc00210 + N/D
LINC00312 + N/D
LOC100507661 + N/D
MALAT1 + +
MANCR + +
MIR22HG + N/D
NEAT1 + N/D
PAR5 + +
PCA3 + N/D
PTCSC3 + +
PVT1 + +
ROR + +
SNHG15 + N/D
SNHG7 + N/D
TNRC6C-AS1 + N/D
TUG1 + +
UCA1 + N/D
XIST + N/D
ZFAS1 + N/D
  1. N/D, not detected; BANCR, BRAF-activated non-protein coding RNA; CASC2, cancer susceptibility candidate 2; CSC, cancer stem cell; FOXD2-AS1, FOXD2 adjacent opposite strand RNA 1; GAS5, growth arrest special 5; HCP5, HLA complex P5; HOTAIR, HOX transcript antisense RNA; HOTAIRM1, hox antisense intergenic RNA myeloid 1; Klhl14, kelch like family member 14; Linc00210, long intergenic non-protein coding RNA 210; LINC00312, long intergenic non-protein coding RNA 312; LncRNA, long noncoding RNA, MALAT1: metastasis-associated lung adenocarcinoma transcript 1; MANCR, mitotically associated long non coding RNA; MIR22HG, MIR22 host gene; NEAT1, nuclear paraspeckle assembly transcript 1; PAR5, Prader Wili/Angelman region RNA 5; PCA3, prostate cancer antigen 3; PTCSC3, papillary thyroid carcinoma susceptibility candidate 3; PVT1, plasmacytoma variant translocation 1; ROR, regulator of reprogramming; SNHG15, small nucleolar RNA host gene 15; SNHG7, small nucleolar RNA host gene 7; TNRC6C-AS1, TNRC6C antisense RNA 1; TUG1, taurine up-regulated gene 1;UCA1, urothelial carcinoma-associated 1; XIST, X inactive specific transcript; ZFAS1, ZNFX1 antisense RNA 1